dbv-technologies.com | DBV Technologies | Dedicated to Improving the Lives of Patients with Food Allergies and Other

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Disallow: /cart Disallow: /wishlist Disallow: /checkout Disallow: /my-account Disallow: /?orderby Disallow: /?filter Disallow: /add-to-cart=* Disallow: /?add_do_wishlist= Allow: /wp-admin/admin-ajax.php Crawl-delay: 10 User-agent: PetalBot Disallow: / User-agent: SemrushBot Disallow: / User-agent: AhrefsBot Disallow: / Sitemap:

Meta Tags

Title	DBV Technologies \| Dedicated to Improving the Lives of Patients with Food Allergies and Other
Description	About DBVDedicated to Improving the Lives of Patients with Food Allergies and Other Immunological DBV Technologies is a global clinical stage biopharmaceutical company founded by pediatricians who believed that food allergies could one day be treated safely and
Keywords	N/A

Server Information

WebSite	dbv-technologies.com
Host IP	192.124.249.163
Location	-

Related Websites

                        Site
                        Rank
                    

More to Explore

dcmarketingproducts.com

duvalautowholesale.com

easternapiculture.org

easymovers.ae

educatoralexander.com

eepcon.com

eganelectrical.com.au

embassyloans.com

enjoy-work.com

enkochem.com

dbv-technologies.com Valuation

US$13,708,941

Last updated: 2023-05-03 12:49:30

dbv-technologies.com has Semrush global rank of 772,073. dbv-technologies.com has an estimated worth of US$ 13,708,941, based on its estimated Ads revenue. dbv-technologies.com receives approximately 1,581,801 unique visitors each day. Its web server is located in -, with IP address 192.124.249.163. According to SiteAdvisor, dbv-technologies.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$13,708,941
Daily Ads Revenue	US$12,655
Monthly Ads Revenue	US$379,633
Yearly Ads Revenue	US$4,555,587
Daily Unique Visitors	105,454
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
dbv-technologies.com.	A	3600	IP: 192.124.249.163
dbv-technologies.com.	NS	10800	NS Record: ns-27-b.gandi.net.
dbv-technologies.com.	NS	10800	NS Record: ns-225-a.gandi.net.
dbv-technologies.com.	NS	10800	NS Record: ns-134-c.gandi.net.
dbv-technologies.com.	MX	3600	MX Record: 0 dbvtechnologies-com0i.mail.protection.outlook.com.
dbv-technologies.com.	TXT	1800	TXT Record: apple-domain-verification=1Isqv4Az5deZIk56
dbv-technologies.com.	TXT	1800	TXT Record: docusign=8a8654db-1d29-41e1-b7c4-45a5a147648b
dbv-technologies.com.	TXT	1800	TXT Record: MS=ms25409075
dbv-technologies.com.	TXT	1800	TXT Record: docusign=baacbf3a-6886-4bc3-83ce-03128aec1c6a
dbv-technologies.com.	TXT	1800	TXT Record: v=spf1 include:spf.protection.outlook.com ip4:217.73.9.208/28 ip4:195.68.103.52/32 ip4:195.144.18.76/32 ip4:195.144.18.201/32 ip4:195.144.18.204/32 ip4:195.144.18.230/32 ip4:195.144.18.231/32 include:mailgun.org -all
dbv-technologies.com.	TXT	1800	TXT Record: kikjg5es5tq6cu6ttpptitb0hi
dbv-technologies.com.	TXT	1800	TXT Record: uspss9rtf1rblmq6io7se2varj

HtmlToTextCheckTime:2023-05-03 12:49:30

English Français Careers Contact Us About DBV Menu Toggle Overview Leadership Our Pipeline Menu Toggle Overview Clinical Trials Viaskin™ Peanut Viaskin™ Milk Viaskin™ Milk for EoE Expanded Access Program Our Science Menu Toggle Overview Viaskin Platform Technology Scientific Publications & Presentations Investors Menu Toggle Investor Overview News Financial Information SEC Filings AMF Regulated Information Events Annual General Meetings Stock Information Corporate Governance FAQs News Main Menu About DBV Dedicated to Improving the Lives of Patients with Food Allergies and Other Immunological Diseases Learn more DBV Technologies is a global clinical stage biopharmaceutical company founded by pediatricians who believed that food allergies could one day be treated safely and effectively. We are on a journey to advance epicutaneous immunotherapy, using our innovative technology platform, Viaskin™ We are exploring the first epicutaneous immunotherapy (EPIT™) treatment for peanut allergy We

HTTP Headers

HTTP/1.1 301 Moved Permanently
Server: Sucuri/Cloudproxy
Date: Mon, 25 Oct 2021 18:56:48 GMT
Content-Type: text/html
Content-Length: 162
Connection: keep-alive
X-Sucuri-ID: 20013
Location: https://dbv-technologies.com/

HTTP/2 301 
server: nginx
date: Mon, 25 Oct 2021 18:56:48 GMT
content-type: text/html; charset=iso-8859-1
content-length: 241
location: https://www.dbv-technologies.com/
x-sucuri-id: 20013
x-xss-protection: 1; mode=block
x-frame-options: SAMEORIGIN
x-content-type-options: nosniff
content-security-policy: upgrade-insecure-requests;
x-sucuri-cache: EXPIRED

HTTP/2 200 
server: nginx
date: Mon, 25 Oct 2021 18:56:49 GMT
content-type: text/html; charset=UTF-8
content-length: 21525
x-sucuri-id: 20013
x-xss-protection: 1; mode=block
x-frame-options: SAMEORIGIN
x-content-type-options: nosniff
content-security-policy: upgrade-insecure-requests;
link: ; rel="https://api.w.org/"
link: ; rel=shortlink
x-tec-api-version: v1
x-tec-api-root: https://www.dbv-technologies.com/wp-json/tribe/events/v1/
x-tec-api-origin: https://www.dbv-technologies.com
vary: Accept-Encoding
content-encoding: gzip
x-sucuri-cache: HIT

dbv-technologies.com Whois Information

Domain Name: DBV-TECHNOLOGIES.COM
Registry Domain ID: 96470896_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.gandi.net
Registrar URL: http://www.gandi.net
Updated Date: 2021-03-04T07:04:40Z
Creation Date: 2003-04-04T09:55:34Z
Registry Expiry Date: 2022-04-04T08:55:34Z
Registrar: Gandi SAS
Registrar IANA ID: 81
Registrar Abuse Contact Email: abuse@support.gandi.net
Registrar Abuse Contact Phone: +33.170377661
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS-134-C.GANDI.NET
Name Server: NS-225-A.GANDI.NET
Name Server: NS-27-B.GANDI.NET
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-13T21:35:34Z <<<

dbv-technologies.com valuation and analysis